TB Archives – Treatment Action Group

Statement on the UN High Level Meeting on Antimicrobial Resistance Final Draft Political Declaration

September 25, 2024
Dorrit Walsh

Treatment Action Group (TAG) congratulates Malta and Barbados, co-facilitators, and all United Nations (UN) Member States participating in the High-Level Meeting on Antimicrobial Resistance (AMR) upon the publication of the final draft of the Political Declaration.

2024 Research in Action Awards Celebrate Leaders in Global Health Activism Who Exemplify TAG’s Mission

September 16, 2024
Dorrit Walsh

Treatment Action Group’s (TAG) most important fundraising event of the year is the Research in Action Awards, which honor the best and brightest activists, researchers, leaders, and scientists whose work has been integral in ending HIV, tuberculosis (TB), and hepatitis C (HCV).

Treatment Action Group Calls for Coordinated, Fully Funded Global Response to Mpox Emergency

August 14, 2024
Dorrit Walsh

Treatment Action Group (TAG) supports the World Health Organization (WHO) in declaring the renewed outbreak of mpox a public health emergency of international concern.

Three New Members Elected to TAG’s Board of Directors

July 25, 2024
Dorrit Walsh

Treatment Action Group (TAG) elected three new members to its Board of Directors in May 2024. Board President Ivy Kwan Arce said, "TAG is reinvigorating its Board in alignment with our vision, mission, and values.

2024 Pipeline Report

July 18, 2024
Dorrit Walsh

Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

2023 Annual Report

July 17, 2024
Dorrit Walsh

We're pleased to share with you our latest Annual Report, which highlights everything we accomplished in 2023.

Call For New Global TB CAB Members

June 26, 2024
Dorrit Walsh

On behalf of the Global Tuberculosis Community Advisory Board (TB CAB), we're excited to announce a call for new member applications.

TAG Calls on Danaher to Drop the Prices of GeneXpert Tests and Make the Cost Audit Public

June 26, 2024
Dorrit Walsh

Treatment Action Group (TAG) calls on Danaher to lower the price of GeneXpert tests for tuberculosis (TB) and other diseases to $5 each in accordance with publicly available evidence of the cost of manufacturing and to commit to public transparency of the cost audit of Xpert MTB/RIF Ultra.

An Open Letter to Médecins Sans Frontières — Urgent Call to Reverse the Devastating Decision to Shutter the MSF Access Campaign

June 20, 2024
Dorrit Walsh

TAG's emergency plea to our allies at MSF to preserve its life-saving and world-changing MSF Access Campaign (Campaign for Access to Essential Medicines) — we need them now more than ever!

Comments Delivered at the WHO Director-General’s TB Vaccine Accelerator Council

May 30, 2024
Dorrit Walsh

These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 2nd meeting of the WHO Director-General’s TB Vaccine Accelerator Council in Geneva Switzerland.